US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Assertio Holdings, Inc. - Common Stock (NQ:ASRT)

23.50 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Assertio Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Assertio Announces Completion of Merger with Zydus Lifesciences and Fundamental Change and Make-Whole Fundamental Change Relating to its Outstanding 6.50% Convertible Senior Notes due 2027
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Shareholder Alert: Ademi LLP investigates whether Assertio Holdings Inc. is obtaining a Fair Price for Public Shareholders
From Ademi LLP
Via GlobeNewswire
News headline image
Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Assertio to Be Acquired by Zydus Worldwide DMCC for $23.50 Per Share in Cash
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Assertio and Garda Mutually Agree to Delay Launch of Tender Offer
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Assertio and Garda Mutually Agree to Postpone Commencement of Tender Offer
From Assertio Holdings, Inc.
Via Business Wire
Traders are paying attention to the gapping stocks in Monday's session. ↗
Via Chartmill
Discover the top movers in Monday's pre-market session. ↗
Via Chartmill
News headline image
Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Assertio and Garda Mutually Agree to Extend Tender Offer Deadline
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Assertio Provides Update on Garda Therapeutics Tender Process
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Halper Sadeh LLC is Investigating Whether WSR, MKC, OMEX, ASRT are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether EHAB, WSR, SEM, ASRT are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
ASRT Stock Alert: Halper Sadeh LLC is Investigating Whether Assertio Holdings, Inc. is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
ASRT Stock Alert: Halper Sadeh LLC is Investigating Whether Assertio Holdings, Inc. is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Assertio Announces Agreement to be Acquired by Garda Therapeutics
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Assertio (ASRT) Q4 2025 Earnings Call Transcript ↗
Assertio (ASRT) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Assertio Reports Fourth Quarter and Full Year 2025 Financial Results
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Monday's after hours session: top gainers and losers ↗
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
News headline image
Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split
From Assertio Holdings, Inc.
Via Business Wire
News headline image
Wondering what's happening in today's pre-market session? ↗
Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
On Monday, there are stocks with unusual volume. Let's take a look. ↗
The trading volume of these stocks is deviating from the norm in today's session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Assertio Holdings Inc (NASDAQ:ASRT) Delivers Strong Q3 Beat as Rolvedon Sales Drive Performance ↗
Assertio Holdings smashed Q3 2025 earnings estimates, driven by surging sales of its key product, Rolvedon. The stock surged on the strong results. 
Via Chartmill
News headline image
These stocks are moving in today's after hours session ↗
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
Assertio Reports Third Quarter 2025 Financial Results
From Assertio Holdings, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >